This study investigates the benefits of minimal residual disease in a subset of AML patients with inv(16) by means of non-quantitative detection of CBFβ/MYH11 fusion transcript. We found that CBFβ/MYH11 RT-PCR negativity is associated with cure of disease.
|Number of pages||3|
|Publication status||Published - May 2000|
ASJC Scopus subject areas